Li Yan
Chief Tech/Sci/R&D Officer at Brii Biosciences Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gregg Alton | M | 58 |
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 3 years |
| Martin Murphy | M | 81 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 3 years |
| Yiu Wa Tsui | M | 74 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 3 years |
| Hui Tang | F | 64 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 3 years |
| Yong Qing Luo | M | 54 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 3 years |
| An Kang Li | M | 47 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 4 years |
| Zhi Hong | M | 60 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 6 years |
| Tai Yin Yang | M | 70 | 2 years | |
| Robert Nelsen | M | 60 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 6 years |
| Qing Zhu | M | 57 | 6 years | |
| Axel Bouchon | M | 52 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 2 years |
| Karen D. Neuendorff | M | 49 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 2 years |
| Eleanor de Groot | M | 55 | 2 years | |
| Wing Tsz Ho | F | 54 | 3 years | |
| Susannah Cantrell | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Alex Mallouk | M | - |
University of Kansas
| 7 years |
| Jeremy D. Tasset | M | - |
University of Kansas
| 4 years |
| Tim Burger | M | - |
University of Kansas
| 9 years |
| Sara Peng | F | - |
University of Kansas
| 4 years |
| Ke Xiang Zhou | M | 60 |
Peking University Health Science Center
| 6 years |
| Michael Maddox | M | 54 |
University of Kansas
| 7 years |
| Zhao Long Gong | M | 60 |
Peking University Health Science Center
| 1 years |
| Hui Ou Yang | M | 52 |
Peking University Health Science Center
| 7 years |
| Ryan M. Sprott | M | 51 |
University of Kansas
| 5 years |
| Jasvindarjit Singh | M | - |
University of Kansas
| 2 years |
| Jeremy Bezdek | M | 49 |
University of Kansas
| 4 years |
| Hiroaki Serizawa | M | - |
University of Kansas
| 7 years |
| Steve Fanelli | M | - |
University of Kansas
| 4 years |
| Lu Wen Shi | M | 60 |
Peking University Health Science Center
| 4 years |
| William W. Casey | M | - |
University of Kansas
| 3 years |
| John Brandmeyer | M | - |
University of Kansas
| 5 years |
| Tonya Mater | F | 46 |
University of Kansas
| 5 years |
| John M. Kosciulek | M | - |
University of Kansas
| 4 years |
| Thomas Meier | M | - |
University of Kansas
| 4 years |
| Russell G. Stone | M | 49 |
University of Kansas
| 4 years |
| M. Grae Griffin | M | - |
University of Kansas
| 4 years |
| Maureen Short | F | 49 |
University of Kansas
| 4 years |
| Liz Meitus | F | - |
University of Kansas
| 3 years |
| Jeffrey Stowell | M | - |
University of Kansas
| 4 years |
| Jake Barnes | M | - |
University of Kansas
| 4 years |
| De Min Zhou | M | 58 |
Peking University Health Science Center
| 4 years |
| Zhi Qian Zhang | M | 57 |
Peking University Health Science Center
| 1 years |
| Matthew E Rubin | F | - |
University of Kansas
| 4 years |
| Xiao Lin Cheng | M | 61 |
Peking University Health Science Center
| 3 years |
| Xiao Lin Hu | M | 63 |
University of Kansas
| 3 years |
| JC Xu | M | 60 |
Peking University Health Science Center
| 3 years |
| Jin Jin Liang | M | 55 |
Peking University Health Science Center
| 4 years |
| Scott Williamson | M | - |
University of Kansas
| 4 years |
| Jian Zhong Liu | M | 59 |
Peking University Health Science Center
| 4 years |
| Thomas J. Lynn | M | - |
University of Kansas
| 4 years |
| Brian Smith | M | - |
University of Kansas
| 4 years |
| Andrew Stout | M | - |
University of Kansas
| 4 years |
| Yu Zhang | M | 52 |
Peking University Health Science Center
| 4 years |
| Gary Winfield Decker | M | - |
University of Kansas
| 2 years |
| Shane Martin Haas | M | - |
University of Kansas
| 6 years |
| Gregg Potter | M | - |
University of Kansas
| 4 years |
| Laura Parada | M | - |
University of Kansas
| 4 years |
| Michael Fischer | M | - |
University of Kansas
| 4 years |
| Mike G. Jonagan | M | - |
University of Kansas
| 7 years |
| Alan T. Dickey | M | - |
University of Kansas
| 4 years |
| Fred Coulson | M | - |
University of Kansas
| 10 years |
| De Jian Liu | M | 52 |
University of Kansas
| 4 years |
| Andy Moore | M | - |
University of Kansas
| 4 years |
| Robert Tracy | M | - |
University of Kansas
| 4 years |
| Amanda Goller | F | - |
University of Kansas
| 4 years |
| Raymond Janssen | M | - |
University of Kansas
| 4 years |
| Mark A. Whitaker | M | - |
University of Kansas
| 4 years |
| Ryan Burke Bailes | M | - |
University of Kansas
| 4 years |
| Robert James Grunzinger | M | - |
University of Kansas
| 4 years |
| Don Kuanglun Kuo | M | - |
University of Kansas
| 4 years |
| Chad Gunther | M | - |
University of Kansas
| 4 years |
| Brad D. Davis | M | - |
University of Kansas
| 4 years |
| Craig Barton Novorr | M | - |
University of Kansas
| 4 years |
| Traci Jensen | F | 57 |
University of Kansas
| 3 years |
| Brook Minx | M | - |
University of Kansas
| 4 years |
| Lance T. LeMay | M | - |
University of Kansas
| 4 years |
| Jun Bao | M | 58 |
University of Kansas
| 3 years |
| Massimiliano Pozzoni | M | 47 |
University of Kansas
| 4 years |
| Justin Roberts Sumner | M | - |
University of Kansas
| 3 years |
| Kenneth Hillman | M | - |
University of Kansas
| 4 years |
| Grant Moise | M | 48 |
University of Kansas
| 4 years |
| Scott Zimmerman | M | 48 |
University of Kansas
| 4 years |
| Eric Chadwick | M | 48 |
University of Kansas
| 4 years |
| Tom Pollock | M | - |
University of Kansas
| 4 years |
| Meng Jun Liu | M | 58 |
Peking University Health Science Center
| 3 years |
| Jim kunce | M | - |
University of Kansas
| 4 years |
| Dean Newton | M | - |
University of Kansas
| 5 years |
| Chris Costello | M | - |
University of Kansas
| 4 years |
| Charlie Ammeen | M | - |
University of Kansas
| 4 years |
| Bryan Breckenridge | M | - |
University of Kansas
| 4 years |
| Adrienne Turner | F | - |
University of Kansas
| 4 years |
| Andrew Bunten | M | 49 |
University of Kansas
| 4 years |
| Patrick Quinlan | M | - |
University of Kansas
| 4 years |
| Jack A. Bowling | M | - |
University of Kansas
| 4 years |
| Jon L'heureux | M | - |
University of Kansas
| 4 years |
| Cindy Rock | F | - |
University of Kansas
| 5 years |
| Curt Isernhagen | M | - |
University of Kansas
| 4 years |
| Susan Ball | F | - |
University of Kansas
| 4 years |
| Jack Christopher Ball | M | - |
University of Kansas
| 5 years |
| Tong Li | M | 55 |
Peking University Health Science Center
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 82 | 82.00% |
| Cayman Islands | 14 | 14.00% |
| China | 13 | 13.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Li Yan
- Personal Network
